PTC Therapeutics Get Positive CHMP Opinion For Sephience For The Treatment Of Phenylketonuria
25/4 15:14
(RTTNews) - PTC Therapeutics, Inc. (PTCT) Friday said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Sephience for the treatment of phenylketonuria, an inherited genetic disorder....